These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10344339)

  • 1. Ischaemic heart disease after renal transplantation: how to assess and minimize the risk.
    Wheeler DC
    Nephrol Dial Transplant; 1999 May; 14(5):1075-7. PubMed ID: 10344339
    [No Abstract]   [Full Text] [Related]  

  • 2. Ischaemic heart disease following renal transplantation.
    Stewart G; Jardine AG; Briggs JD
    Nephrol Dial Transplant; 2000 Feb; 15(2):269-77. PubMed ID: 10648681
    [No Abstract]   [Full Text] [Related]  

  • 3. Ischemic heart disease after renal transplantation.
    Kasiske BL
    Kidney Int; 2002 Jan; 61(1):356-69. PubMed ID: 11786124
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal impairment: a risk factor for ischemic heart disease.
    Zoccali C
    Curr Opin Pharmacol; 2006 Apr; 6(2):221-5. PubMed ID: 16483843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic heart disease in renal transplant candidates: towards non-invasive approaches for preoperative risk stratification.
    Feringa HH; Bax JJ; Schouten O; Poldermans D
    Eur J Echocardiogr; 2005 Oct; 6(5):313-6. PubMed ID: 16085465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis, diagnosis and conservative treatment of ischemic heart disease in patients with chronic renal failure].
    Imiela J
    Pol Arch Med Wewn; 2000 Oct; 104(4):671-9. PubMed ID: 11392155
    [No Abstract]   [Full Text] [Related]  

  • 7. Are cardiac troponins reliable serodiagnositic markers of cardiac ischaemia in end-stage renal disease?
    Haller C; Stevanovich A; Katus HA
    Nephrol Dial Transplant; 1996 Jun; 11(6):941-4. PubMed ID: 8671943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic renal failure and ischemic heart disease].
    Mukai S; Kimura G
    Nihon Rinsho; 2003 May; 61 Suppl 5():880-3. PubMed ID: 12809049
    [No Abstract]   [Full Text] [Related]  

  • 9. Pilot cohort study on the potential role of TCF7L2 rs7903146 on ischemic heart disease among non-diabetic kidney transplant recipients.
    Quaglia M; Musetti C; Merlotti G; Genazzani AA; Cargnin S; Cena T; Cantaluppi V; Terrazzino S
    Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28299838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac ischemia in the diabetic patient with end-stage renal disease.
    Churchill DN
    Perit Dial Int; 1999; 19(4):305-8. PubMed ID: 10507807
    [No Abstract]   [Full Text] [Related]  

  • 11. [The cardiovascular risk after renal transplantation (1): Hypertension and left ventricular hypertrophy].
    Covic A; Gusbeth-Tatomir P; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):651-6. PubMed ID: 12092214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity as a risk factor in renal transplant patients.
    Pischon T; Sharma AM
    Nephrol Dial Transplant; 2001 Jan; 16(1):14-7. PubMed ID: 11208986
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolution of bone mineral density after renal transplantation: related factors.
    Torregrosa JV; Campistol JM; Montesinos M; Pons F; Martinez de Osaba MJ
    Nephrol Dial Transplant; 1995; 10 Suppl 6():111-3. PubMed ID: 8524478
    [No Abstract]   [Full Text] [Related]  

  • 14. [Silent ischemia in patients on dialysis treatment].
    Cice G; Di Benedetto A; Sarubbi B; Tedesco MA; Iacono A
    Cardiologia; 1994 Sep; 39(9):629-32. PubMed ID: 7859229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there something special about ischemic heart disease in patients undergoing dialysis?
    Herzog CA
    Am Heart J; 2004 Jun; 147(6):942-4. PubMed ID: 15199336
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurodevelopment of infants with end-stage renal disease: is it improving?
    Warady BA
    Pediatr Transplant; 2002 Feb; 6(1):5-7. PubMed ID: 11906634
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired Left Ventricular Global Longitudinal Strain among Patients with Chronic Kidney Disease and End-Stage Renal Disease and Renal Transplant Recipients.
    Ravera M; Rosa GM; Fontanive P; Bussalino E; Dorighi U; Picciotto D; Di Lullo L; Dini FL; Paoletti E
    Cardiorenal Med; 2019; 9(1):61-68. PubMed ID: 30485849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disorders of lipid metabolism in patients with chronic renal failure and after kidney transplantation].
    Klin M
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):667-70. PubMed ID: 1492031
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease.
    Sharma R; Gaze DC; Pellerin D; Mehta RL; Gregson H; Streather CP; Collinson PO; Brecker SJ
    Clin Sci (Lond); 2007 Jul; 113(1):25-32. PubMed ID: 17284166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone treatment in children before and after renal transplantation.
    Hokken-Koelega AC
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():359-64. PubMed ID: 8887181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.